Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma

Withdrawn before enrolling

Conditions studied: Glioblastoma, Glioma

In brief

This clinical trial studies how well delayed fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) works in improving visualization of brain tumors in patients with glioblastoma. Radiotracers such as 18F-FDG are highly taken up by tumors in the brain and are visualized using PET/CT. Increasing the interval of time between 18F-FDG administration and PET/CT scan may improve the visualization of brain tumors in patients with glioblastoma.

Key facts

Study ID

NCT02919332

Run by

Jonsson Comprehensive Cancer Center

People needed

0

Starts

2016-06-08

Expected to finish

2018-12-12

Last updated by the study team

2020-07-24

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with histologically proven high grade glioma scheduled for 18F-FDG PET/CT

You may not qualify if…

• Severe psychiatric illness
• Inability to give written consent
• Breast feeding/pregnancy

Where it is running

• UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.